This is a routine filing. Monitor the company's next earnings release or significant news for potential trading opportunities.
Price Chart
Executive Summary
Crescent Biopharma, Inc. (CBIO) has filed a definitive proxy statement (DEFA14A) for an upcoming shareholder meeting. The filing is a routine disclosure required by the SEC, detailing matters to be voted on by shareholders, such as the election of directors, executive compensation, and other corporate governance issues. The document does not contain any material financial data or significant events that would impact the stock price in the near term.
Key Financial Metrics
Key Facts
- The filing is a definitive proxy statement (DEFA14A) for a shareholder meeting.
- It is a routine disclosure required by the SEC.
- The document details matters to be voted on by shareholders, such as the election of directors and executive compensation.
- No material financial data or significant events are disclosed.
Financial Impact
No material financial impact.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001628280-26-026291 |
| Document: 0001628280-26-026291-index-headers.html | 0001628280-26-026291 |
| Document: 0001628280-26-026291-index.html | 0001628280-26-026291 |
| Document: 0001628280-26-026291.txt | 0001628280-26-026291 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 12d ago | 8-K | $11.84 | awaiting T+60 | — | $13.27 (+12.08%) |
Oct 15, 2026 12d ago | Press Release | $11.84 | awaiting T+60 | — | $13.27 (+12.08%) |
Oct 5, 2026 22d ago | Press Release | $13.94 | awaiting T+60 | — | $13.27 (−4.81%) |
Sep 18, 2026 5w ago | Insider Cluster | $16.25 | awaiting T+60 | — | $13.27 (−18.34%) |
Jul 30, 2026 12w ago | 8-K | $15.02 $12.82 | ▼ −14.65% | ▼ −17.11% | $13.27 (−11.65%) |
Jul 20, 2026 14w ago | Insider Buy | $16.64 $12.91 | ▼ −22.42% | ▼ −26.39% | $13.27 (−20.25%) |
Jul 15, 2026 14w ago | 8-K / 424B5 | $15.11 $14.91 | ▲ +1.32% | ▲ +5.03% | $13.27 (+12.18%) |
Jul 14, 2026 15w ago | Press Release | $15.67 $14.12 | ▲ +9.89% | ▲ +12.42% | $13.27 (+15.32%) |
Jul 14, 2026 15w ago | 424B5 | $15.67 $14.12 | ▲ +9.89% | ▲ +12.42% | $13.27 (+15.32%) |
Jul 13, 2026 15w ago | EFFECT | $15.69 $13.57 | ▼ −13.51% | ▼ −17.51% | $13.27 (−15.42%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers